Interneuron, interrupted: Molecular pathogenesis of ARX mutations and X-linked infantile spasms

Current Opinion in Neurobiology

Volumn 22, Issue 5, 2012, Pages 859-865

  Olivetti, Pedro R ^a   Noebels, Jeffrey L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARISTALESS RELATED HOMEOBOX GENE; CELL MATURATION; CELL MIGRATION; EPILEPSY; GENE; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANTILE SPASM; INTELLECTUAL IMPAIRMENT; INTERNEURON; INTRACTABLE EPILEPSY; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; X LINKED INFANTILE SPASM SYNDROME;

AICARDI SYNDROME; ANIMALS; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; INTERNEURONS; MICE; MUTATION; SPASMS, INFANTILE; TRANSCRIPTION FACTORS;

EID: 84868203852     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2012.04.006     Document Type: Review

References (45)

1. Paciorkowski A.R., Thio L.L., Dobyns W.B. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011, 45:355-367.
2. Hamano S.-I., Yamashita S., Tanaka M., Yoshinari S., Minamitani M., Eto Y. Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in west syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause. J Pediatr 2006, 148:485-488.
3. Partikian A., Mitchell W.G. Major adverse events associated with treatment of infantile spasms. J Child Neurol 2007, 22:1360-1366.
4. Ohya T., Nagai T., Araki Y., Yanagawa T., Tanabe T., Iyoda K., Kurihara M., Yamamoto K., Masunaga K., Iizuka C., et al. A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome. Brain Dev 2009, 31:739-743.
5. Frost J., Hrachovy R. Infantile Spasms: Diagnosis, Management and Prognosis 2003, Kluwer.
6. Mackay M.T., Weiss S.K., Adams-Webber T., Ashwal S., Stephens D., Ballaban-Gill K., Baram T.Z., Duchowny M., Hirtz D., Pellock J.M., et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668-1681.
7. Gayatri N.A., Ferrie C.D., Cross H. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev 2007, 10.1002/14651858.CD005222.pub2.
8. Chudomelova L., Scantlebury M.H., Raffo E., Coppola A., Betancourth D., Galanopoulou A.S. Modeling new therapies for infantile spasms. Epilepsia 2010, 51:27-33.
9. Pellock J.M., Hrachovy R., Shinnar S., Baram T.Z., Bettis D., Dlugos D.J., Gaillard W.D., Gibson P.A., Holmes G.L., Nordl D.R., et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010, 51:2175-2189.
10. Strømme P., Mangelsdorf M.E., Scheffer I.E., Gécz J. Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX. Brain Dev 2002, 24:266-268.
11. Strømme P., Mangelsdorf M.E., Shaw M.A., Lower K.M., Lewis S.M.E., Bruyere H., Lütcherath V., Gedeon Á.K, Wallace R.H., Scheffer I.E., et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002, 30:441-445.
12. Turner G., Partington M., Kerr B., Mangelsdorf M., Gécz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identicalARX gene mutation. Am J Med Genet 2002, 112:405-411.
13. Bienvenu T., Poirier K., Friocourt G., Bahi N., Beaumont D., Fauchereau F., Ben Jeema L., Zemni R., Vinet M.-C., Francis F., et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 2002, 11:981-991.
14. Kato M., Das S., Petras K., Kitamura K., Morohashi K.-I., Abuelo D.N., Barr M., Bonneau D., Brady A.F., Carpenter N.J., et al. Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat 2004, 23:147-159.
15. Miura H., Yanazawa M., Kato K., Kitamura K. Expression of a novel aristaless related homeobox gene "Arx" in the vertebrate telencephalon, diencephalon and floor plate. Mech Dev 1997, 65:99-109.
16. Ohira R., Zhang Y.H., Guo W., Dipple K., Shih S.L., Doerr J., Huang B.L., Fu L.J., Abu-Khalil A., Geschwind D., et al. Human ARX gene: genomic characterization and expression. Mol Genet Metab 2002, 77:179-188.
17. Colombo E., Galli R., Cossu G., Gcz J., Broccoli V. Mouse orthologue of ARX, a gene mutated in several X-linked forms of mental retardation and epilepsy, is a marker of adult neural stem cells and forebrain GABAergic neurons. Dev Dyn 2004, 231:631-639.
18. Poirier K., Van Esch H., Friocourt G., Saillour Y., Bahi N., Backer S., Souil E., Castelnau-Ptakhine L., Beldjord C., Francis F., et al. Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons. Brain Res Mol Brain Res 2004, 122:35-46.
19. Cobos I., Calcagnotto M.E., Vilaythong A.J., Thwin M.T., Noebels J.L., Baraban S.C., Rubenstein J.L.R. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 2005, 8:1059-1068.
20. Friocourt G., Poirier K., Rakić S., Parnavelas J.G., Chelly J. The role of ARX in cortical development. Eur J Neurosci 2006, 23:869-876.
21. Colombo E., Collombat P., Colasante G., Bianchi M., Long J., Mansouri A., Rubenstein J.L.R., Broccoli V. Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation. J Neurosci 2007, 27:4786-4798.
22. Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A., Kusaka M., Omichi K., Suzuki R., Kato-Fukui Y., Kamiirisa K., et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 2002, 32:359-369.
23. Shoubridge C., Cloosterman D., Parkinson Lawerence E., Brooks D., Gécz J. Molecular pathology of expanded polyalanine tract mutations in the Aristaless-related homeobox gene. Genomics 2007, 90:59-71.
24. Lin W., Ye W., Cai L., Meng X., Ke G., Huang C., Peng Z., Yu Y., Golden J.A., Tartakoff A.M., et al. The roles of multiple importins for nuclear import of murine aristaless-related homeobox protein. J Biol Chem 2009, 284:20428-20439.
25. Shoubridge C., Tan M., Fullston T., Cloosterman D., Coman D., McGillivray G., Mancini G.M., Kleefstra T., Gécz J. Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division. Pathogenetics 2010, 3:1.
26. Fulp C.T., Cho G., Marsh E.D., Nasrallah I.M., Labosky P.A., Golden J.A. Identification of Arx transcriptional targets in the developing basal forebrain. Hum Mol Genet 2008, 17:3740-3760.
27. Colasante G., Sessa A., Crispi S., Calogero R., Mansouri A., Collombat P., Broccoli V. Arx acts as a regional key selector gene in the ventral telencephalon mainly through its transcriptional repression activity. Dev Biol 2009, 334:59-71.
28. Shoubridge C., Tan M.H., Seiboth G., Gécz J. ARX homeodomain mutations abolish DNA binding and lead to a loss of transcriptional repression. Hum Mol Genet 2011, 10.1093/hmg/ddr601.
29. Nasrallah I.M., Minarcik J.C., Golden J.A. A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol 2004, 167:411-416.
30. Fullston T., Finnis M., Hackett A., Hodgson B., Brueton L., Baynam G., Norman A., Reish O., Shoubridge C., Gécz J. Screening and cell-based assessment of mutations in the Aristaless-related homeobox (ARX) gene. Clin Genet 2011, 80:510-522.
31. Price M.G., Yoo J.W., Burgess D.L., Deng F., Hrachovy R.A., Frost J.D., Noebels J.L. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 2009, 29:8752-8763.
32. Nasrallah M.P., Cho G., Putt M.E., Kitamura K., Golden J.A. Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression. Hum Mol Genet 2011, 10.1093/hmg/ddr538.
33. McKenzie O., Ponte I., Mangelsdorf M., Finnis M., Colasante G., Shoubridge C., Stifani S., Gécz J., Broccoli V. Aristaless-related homeobox gene, the gene responsible for West syndrome and related disorders, is a Groucho/transducin-like enhancer of split dependent transcriptional repressor. NSC 2007, 146:236-247.
34. Cho G., Nasrallah M.P., Lim Y., Golden J.A. Distinct DNA binding and transcriptional repression characteristics related to different ARX mutations. Neurogenetics 2012, 10.1007/s10048-011-0304-7.
35. Topalidou I., van Oudenaarden A., Chalfie M. Caenorhabditis elegans aristaless/Arx gene alr-1 restricts variable gene expression. Proc Natl Acad Sci USA 2011, 108:4063-4068.
36. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Höllt V., Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003, 23:5123-5130.
37. Stumm R., Hollt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J Mol Endocrinol 2007, 38:377-382.
38. Liapi A., Pritchett J., Jones O., Fujii N., Parnavelas J.G., Nadarajah B. Stromal-derived factor 1 signalling regulates radial and tangential migration in the developing cerebral cortex. Dev Neurosci 2008, 30:117-131.
39. Tanaka D.H., Mikami S., Nagasawa T., Miyazaki J.I., Nakajima K., Murakami F. CXCR4 is required for proper regional and laminar distribution of cortical somatostatin-, calretinin-, and neuropeptide Y-expressing GABAergic interneurons. Cereb Cortex 2010, 20:2810-2817.
40. Sánchez-Alcañiz J.A., Haege S., Mueller W., Pla R., Mackay F., Schulz S., López-Bendito G., Stumm R., Marín O. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 2011, 69:77-90.
41. Wang Y., Li G., Stanco A., Long J.E., Crawford D., Potter G.B., Pleasure S.J., Behrens T., Rubenstein J.L.R. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 2011, 69:61-76.
42. Quillé M.-L., Carat S., Quéméner-Redon S., Hirchaud E., Baron D., Benech C., Guihot J., Placet M., Mignen O., Férec C., et al. High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies. PLoS ONE 2011, 6:e25181.
43. Marsh E., Fulp C., Gomez E., Nasrallah I., Minarcik J., Sudi J., Christian S.L., Mancini G., Labosky P., Dobyns W., et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009, 132:1563-1576.
44. Kitamura K., Itou Y., Yanazawa M., Ohsawa M., Suzuki-Migishima R., Umeki Y., Hohjoh H., Yanagawa Y., Shinba T., Itoh M., et al. Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice. Hum Mol Genet 2009, 18:3708-3724.
45. Guerrini R., Moro F., Kato M., Barkovich A.J., Shiihara T., McShane M.A., Hurst J., Loi M., Tohyama J., Norci V., et al. Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology 2007, 69:427-433.